Table 2.
Feature | Family 1 | Family 2 | Family 3 | Family 4 | Family 5 | Family 6 | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Individuals | II.1 | II.2 | I.1 | II.2 (i) | II.4 | III.1 | II.1 | I.2 | II.1 | I.1 | II.1 (i) | II.1 (i) | II.2 |
GHSTs | N/A | N/A | clonidine, ITT | clonidine, ITT | clonidine | N/A | N/A | glucagon, insulin, clonidine | basal neonatal | insulin, l-dopa | arginine, clonidine | ITT | ITT |
GH peak (ng/mL) | N/A | N/A | 7.6 | 0.9 | 0.5 | N/A | N/A | ND | ND | 2.9a | 2.7b | 3.7 mU/L | 3.6 mU/L |
TSH (U/L) | N/A | N/A | 0.6 | 0.7 | 1.7 | N/A | N/A | N/A | 0.28 | N/A | 3.4 | normal | normal |
Total T4 (ug/dL) | N/A | N/A | 6.4 | 6 | 5.6–7.3 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free T4 (ng/dL) | N/A | N/A | 0.7 | 0.6–1.1 | 0.6–0.9 | N/A | N/A | N/A | 0.4 | 0.9 | 1.2 | N/A | N/A |
Prolactin (ng/mL) | N/A | N/A | N/A | 3.8–12 | 3.2–6.6 | N/A | N/A | 2.0 mU/L | 9 mU/L | 8.3 | 4.4 | N/A | N/A |
Cortisol (μg/dL) | N/A | N/A | N/A | peak ITT 42 | normal | N/A | N/A | treated in twenties | 36.2 nmol/L | 13 | 13.2 | N/A | N/A |
LH/FSH | N/A | N/A | N/A | early puberty | normal puberty | N/A | N/A | delayed puberty, spontaneous pregnancy | normal | spontaneous puberty | 0.1/0.75 | spontaneous puberty | N/A |
Abbreviations are as follows: i, index case; N/A, not available; GHSTs, growth hormone stimulation tests; ND, non-detectable; ITT, insulin-tolerance test; LH, luteinizing hormone; FSH, follicle stimulating hormone.
Cut-off 4.8 ng/mL.
Cut-off 10 ng/mL.